product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Cytokeratin, pan Antibody (AE-1/AE-3) - Azide and BSA Free
catalog :
NBP2-33200
quantity :
0.1 mg (also 1 mg)
price :
539 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
AE-1/AE-3
reactivity :
human, mouse, rat, dogs, bovine
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
Novus Biologicals product webpage
citations: 25
Reference
Li R, Li N, Yang Q, Tong X, Wang W, Li C, et al. Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis. Genome Med. 2024;16:148 pubmed publisher
Dong Z, Zhang M, Qu L, Zou J, Yang Y, Ma Y, et al. Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma. Biomark Res. 2024;12:100 pubmed publisher
Kim J, Tierney B, Overbey E, Dantas E, Fuentealba M, Park J, et al. Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight. Nat Commun. 2024;15:4954 pubmed publisher
van Eijck C, Real F, Malats N, Vadgama D, van den Bosch T, Doukas M, et al. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery. Cell Rep Med. 2024;5:101557 pubmed publisher
Rodrigues A, Chernikova S, Wang Y, Trinh T, Solow Cordero D, Alexandrova L, et al. Repurposing mebendazole against triple-negative breast cancer CNS metastasis. J Neurooncol. 2024;168:125-138 pubmed publisher
Park S, Kang M, Kim Y, Kim D, Oh K, Joo K, et al. Glomerular spatial transcriptomics of IgA nephropathy according to the presence of mesangial proliferation. Sci Rep. 2024;14:2211 pubmed publisher
Helgers L, Keijzer N, van Hamme J, Sprokholt J, Geijtenbeek T. Dengue Virus Infects Human Skin Langerhans Cells through Langerin for Dissemination to Dendritic Cells. J Invest Dermatol. 2024;144:1099-1111.e3 pubmed publisher
Riedinger C, Esnakula A, Haight P, Suarez A, Chen W, Gillespie J, et al. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers. Cancer. 2024;130:385-399 pubmed publisher
Uddin M, Al Hallak M, Khan H, Aboukameel A, Li Y, Bannoura S, et al. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clin Transl Med. 2023;13:e1513 pubmed publisher
Schweizer L, Krishnan R, Shimizu A, Metousis A, Kenny H, Mendoza R, et al. Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression. medRxiv. 2023;: pubmed publisher
Huang H, Li N, Liang Y, Li R, Tong X, Xiao J, et al. Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma. Clin Transl Med. 2023;13:e1493 pubmed publisher
Zhou A, Tucker J, Scribano C, Lynch A, Carlsen C, Pop Vicas S, et al. Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar spindles. PLoS Biol. 2023;21:e3002339 pubmed publisher
Ying L, Zhang C, Reuben A, Tian Y, Jin J, Wang C, et al. Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma. iScience. 2023;26:107732 pubmed publisher
Gadwa J, Amann M, Bickett T, Knitz M, Darragh L, Piper M, et al. Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC. Cell Rep Med. 2023;4:101150 pubmed publisher
Jim xe9 nez S xe1 nchez D, L xf3 pez Janeiro x, Villalba Esparza M, Ariz M, Kadioglu E, Masetto I, et al. Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images. NPJ Digit Med. 2023;6:48 pubmed publisher
Park S, Karalis J, Hong C, Clemenceau J, Porembka M, Kim I, et al. ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer. Clin Cancer Res. 2023;29:1077-1085 pubmed publisher
Macchiarella G, Cornacchione V, Cojean C, Riker J, Wang Y, Té H, et al. Disease Association of Anti‒Carboxyethyl Lysine Autoantibodies in Hidradenitis Suppurativa. J Invest Dermatol. 2023;143:273-283.e12 pubmed publisher
Yerly L, Pich Bavastro C, Di Domizio J, Wyss T, Tissot Renaud S, Cangkrama M, et al. Integrated multi-omics reveals cellular and molecular interactions governing the invasive niche of basal cell carcinoma. Nat Commun. 2022;13:4897 pubmed publisher
Ozturk H, Cingoz H, Tufan T, Yang J, Adair S, Tummala K, et al. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Dev Cell. 2022;57:1331-1346.e9 pubmed publisher
Dance Y, Meshulam T, Seibel A, Obenreder M, Layne M, Nelson C, et al. Adipose Stroma Accelerates the Invasion and Escape of Human Breast Cancer Cells from an Engineered Microtumor. Cell Mol Bioeng. 2022;15:15-29 pubmed publisher
Yamamoto H, Elbadawy M, Fujisaka K, Sato Y, Ohmori T, Shinohara Y, et al. Evaluation of the Safety and Feasibility of Apheresis in Dogs: For Application in Metastatic Cancer Research. Animals (Basel). 2021;11: pubmed publisher
Fukushima K, Satoh T, Sugihara F, Sato Y, Okamoto T, Mitsui Y, et al. Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis. Immunity. 2020;52:542-556.e13 pubmed publisher
Oppel F, Tao T, Shi H, Ross K, Zimmerman M, He S, et al. Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies. PLoS Genet. 2019;15:e1008039 pubmed publisher
Wan J, Block S, Scribano C, Thiry R, Esbona K, Audhya A, et al. Mad1 destabilizes p53 by preventing PML from sequestering MDM2. Nat Commun. 2019;10:1540 pubmed publisher
JENSEN T, Wanczyk H, Sharma I, Mitchell A, Sayej W, Finck C. Polyurethane scaffolds seeded with autologous cells can regenerate long esophageal gaps: An esophageal atresia treatment model. J Pediatr Surg. 2018;: pubmed publisher
product information
master code :
NBP2-33200
SKU :
NBP2-33200
product name :
Cytokeratin, pan Antibody (AE-1/AE-3) - Azide and BSA Free
unit size :
0.1 mg (also 1 mg)
description :
The Cytokeratin, pan Antibody (AE-1/AE-3) - Azide and BSA Free from Novus is a mouse monoclonal antibody to Cytokeratin, pan. This antibody reacts with bovine,canine,chicken,human,monkey,mouse,rabbit,rat,reptile,zebrafish,fish - danio rerio (zebrafish). The Cytokeratin, pan Antibody (AE-1/AE-3) - Azide and BSA Free has been validated for the following applications: Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Paraffin,Western Blot,Immunohistochemistry-Frozen,Flow (Intracellular),CyTOF-ready,Single Cell Western,Dual RNAscope ISH-IHC.
target :
Cytokeratin, pan
category :
Primary Antibodies
buffer :
10 mM PBS
clonality :
Monoclonal
clone :
AE-1/AE-3
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Human epidermal keratin
isotype :
IgG1 Kappa/IgG1 Kappa
purity :
Protein A or G purified
species :
Bovine,Canine,Chicken,Human,Monkey,Mouse,Rabbit,Rat,Reptile,Zebrafish,Fish - Danio rerio (Zebrafish)
specificity :
Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6
gene symbol :
KRT1
applications :
Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Western Blot,Immunohistochemistry-Frozen,Flow (Intracellular),CyTOF-ready,Single Cell Western,Dual RNAscope ISH-IHC
USD :
539 USD
alt names :
CK1, CK10, CK13, CK14, CK15, CK16, CK-17, CK-18, CK19, CK20, CK-2e, CK3, CK4, CK5, CK6A, CK8, CK-9, K12, KRT1, KRT10, KRT12, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT20, KRT3, KRT4, krt5, KRT6A, KRT8, KRT9, panck
storage :
Store at -20 to -80C. Avoid freeze-thaw cycles.
more info or order :
Novus Biologicals product webpage
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.